Wasatch Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
RP
ACM
CAM
FWIA
AC
YCM
Wasatch Advisors's MEDP Position: Q2 2026 in Review
Wasatch Advisors reduced its Medpace (MEDP) stake by 18% in Q2 2026, selling an estimated $63.4M and leaving 636,595 shares worth $337M. The position accounts for 2.21% of the portfolio, ranked #5.
Wasatch Advisors first reported a position in MEDP in Q4 2018 and has held it in 31 quarters since. The position peaked at $530M in Q4 2021. 72 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Wasatch Advisors held 636,595 shares of Medpace worth $337M as of Q2 2026.
- Wasatch Advisors sold 137,336 Medpace shares in Q2 2026, an estimated $63.4M.
- Medpace made up 2.21% of Wasatch Advisors's portfolio in Q2 2026, its #5 holding.
- Wasatch Advisors first reported a position in Medpace in Q4 2018 and has held it in 31 quarters since.
- Wasatch Advisors's Medpace position peaked at $530M in Q4 2021.
- 72 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.